Ledger.Open graph →
SEC Form D · filed March 1, 2018

Tempest Therapeutics, Inc

Offering
$70.2M
Sold
$25.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Thomas W. Dubensky, Jr · San Francisco, CAExec · DirectorBradley J. Bolzon · San Francisco, CADirectorRobert J. Weisskoff · San Francisco, CADirectorThomas J. Woiwode · San Francisco, CADirectorStella J. Xu · San Francisco, CADirectorPetpiboon J. Prasit · San Francisco, CADirectorBryan Greene · Syracuse, NYDirectorMary Ann Tyszko · Syracuse, NYDirectorIra Fedder · Syracuse, NYExec · DirectorJeremy Williams · Syracuse, NYDirectorPeter Cohen · Syracuse, NYDirectorAndrew Rock · Syracuse, NYDirectorIvan Markman · CULVER CITY, CADirectorSteven Hamerslag · CULVER CITY, CADirectorJeffrey Pressman · CULVER CITY, CADirectorIgor Vaks · CULVER CITY, CAExec · DirectorDaniel Murray · CULVER CITY, CADirectorNL Series Genpar LLC · Ft. Worth, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗